O-Fucosylation of thrombospondin type 1 repeats

Methods in Enzymology

Volumn 480, Issue C, 2010, Pages 401-416

  Leonhard Melief, Christina ^a   Haltiwanger, Robert S ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOSPONDIN;

ARTICLE; ELECTROSPRAY MASS SPECTROMETRY; FUCOSYLATION; GLYCOSYLATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 77956161887     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(10)80018-7     Document Type: Chapter

References (70)

1. Acar M., et al. Rumi is a CAP10 domain glycosyltransferase that modifies Notch and is required for Notch signaling. Cell 2008, 132:247-258.
2. Adams J.C., Tucker R.P. The thrombospondin type 1 repeat (TSR) superfamily: Diverse proteins with related roles in neuronal development. Dev. Dyn. 2000, 218:280-299.
3. Bjoern S., et al. Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine. J. Biol. Chem. 1991, 266:11051-11057.
4. Bornstein P., et al. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int. J. Biochem. Cell Biol. 2004, 36:1115-1125.
5. Bruckner K., et al. Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature 2000, 406:411-415.
6. Campbell I.D., Bork P. Epidermal growth factor-like modules. Curr. Opin. Struct. Biol. 1993, 3:385-392.
7. Colige A., et al. Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. Am. J. Hum. Genet. 1999, 65:308-317.
8. Dagoneau N., et al. ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome. Am. J. Hum. Genet. 2004, 75:801-806.
9. Dawson D.W., et al. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol. 1997, 138:707-717.
10. Du, et al. O-fucosylation of thrombosponding type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation. Dev. Biol. 2010, (In press).
11. El Hour M., et al. Higher sensitivity of ADAMTS12-deficient mice to tumor growth and angiogenesis. Oncogene 2000, 29:3025-3032.
12. Fiore R., et al. Inactivation of the Sema5a gene results in embryonic lethality and defective remodeling of the cranial vascular system. Mol. Cell. Biol. 2005, 25:2310-2319.
13. Furmanek A., Hofsteenge J. Protein C-mannosylation: Facts and questions. Acta Biochim. Pol. 2000, 47:781-789.
14. Glasson S.S., et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum. 2004, 50:2547-2558.
15. Glasson S.S., et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005, 434:644-648.
16. Gonzalez de Peredo A., et al. C-mannosylation and O-fucosylation of thrombospondin type 1 repeats. Mol. Cell. Proteomics 2002, 1:11-18.
17. Greene V.B., et al. Confirmation of ADAMTSL4 mutations for autosomal recessive isolated bilateral ectopia lentis. Ophthalmic Genet. 2010, 31:47-51.
18. Hallgreen P., et al. A new type of carbohydrate-protein linkage in glycopeptide form normal human urine. J. Biol. Chem. 1975, 250:5312-5314.
19. Harris R.J., Spellman M.W. O-linked fucose and other post-translational modifications unique to EGF modules. Glycobiology 1993, 3:219-224.
20. Harris R.J., et al. Tissue plasminogen activator has an O-linked fucose attached to threonine-61 in the epidermal growth factor domain. Biochemistry 1991, 30:2311-2314.
21. Harris R.J., et al. O-linked fucose is present in the first epidermal growth factor domain of factor XII but not protein C. J. Biol. Chem. 1992, 267:5102-5107.
22. Harris R.J., et al. Identification and structural analysis of the tetrasaccharide NeuAc alpha(2->6)Gal beta(1->4)GlcNAc beta(1->3)Fuc alpha 1->O-linked to serine 61 of human factor IX. Biochemistry 1993, 32:6539-6547.
23. Hartmann S., Hofsteenge J. Properdin, the positive regulator of complement, is highly C-mannosylated. J. Biol. Chem. 2000, 275:28569-28574.
24. Hess D., et al. Peters Plus syndrome is a new congenital disorder of glycosylation and involves defective Omicron-glycosylation of thrombospondin type 1 repeats. J. Biol. Chem. 2008, 283:7354-7360.
25. Hofsteenge J., et al. C-mannosylation and O-fucosylation of the thrombospondin type 1 module. J. Biol. Chem. 2001, 276:6485-6498.
26. Hurvitz J.R., et al. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat. Genet. 1999, 23:94-98.
27. Ivkovic S., et al. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 2003, 130:2779-2791.
28. Jones G.C., Riley G.P. ADAMTS proteinases: A multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Res. Ther. 2005, 7:160-169.
29. Kentzer E.J., et al. Carbohydrate composition and presence of fucose-protein linkage in recombinant human pro-urokinase. Biochem. Biophys. Res. Commun. 1990, 171:401-406.
30. Kimura Y., et al. Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 2008, 111:732-740.
31. Klinger M.M., et al. Characterization of novel amino acid fucosides. J. Biol. Chem. 1981, 256:7932-7935.
32. Koo B.H., Apte S.S. Cell-surface processing of the metalloprotease pro-ADAMTS9 is influenced by the chaperone GRP94/gp96. J. Biol. Chem. 2010, 285:197-205.
33. Kozma K., et al. Identification and characterization of abeta1,3-glucosyltransferase that synthesizes the Glc-beta1, 3-Fuc disaccharide on thrombospondin type 1 repeats. J. Biol. Chem. 2006, 281:36742-36751.
34. Kyriakides T.R., et al. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J. Cell Biol. 1998, 140:419-430.
35. Lawler J., et al. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J. Clin. Invest. 1998, 101:982-992.
36. Le Goff C., et al. Regulation of procollagen amino-propeptide processing during mouse embryogenesis by specialization of homologous ADAMTS proteases: Insights on collagen biosynthesis and dermatosparaxis. Development 2006, 133:1587-1596.
37. Le Goff C., et al. ADAMTSL2 mutations in gelophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation. Nat. Genet. 2008, 40:1119-1123.
38. Lee Tom v., Takeuchi Heyuki, Jafar-Nejad Hamed Regulation of Notch signaling via O-glucosylation: Insights from Drosophila studies. Methods Enzymol. 2010, 480:375-398.
39. Lesnik Oberstein S.A., et al. Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase. Am. J. Hum. Genet. 2006, 79:562-566.
40. Li S.W., et al. Transgenic mice with inactive alleles for procollagen N-proteinase (ADAMTS-2) develop fragile skin and male sterility. Biochem. J. 2001, 355:271-278.
41. Luo Y., et al. Protein O-fucosyltransferase 2 adds O-fucose to thrombospondin type 1 repeats. J. Biol. Chem. 2006, 281:9393-9399.
42. Luo Y., et al. Two distinct pathways for O-fucosylation of epidermal growth factor-like or thrombospondin type 1 repeats. J. Biol. Chem. 2006, 281:9385-9392.
43. Luther K.B., Haltiwanger R.S. Role of unusual O-glycans in intercellular signaling. Int. J. Biochem. Cell Biol. 2009, 41:1011-1024.
44. Majerus E.M., et al. Binding of ADAMTS13 to von Willebrand factor. J. Biol. Chem. 2005, 280:21773-21778.
45. Mo F.E., et al. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol. Cell. Biol. 2002, 22:8709-8720.
46. Moloney D.J., et al. The O-linked fucose glycosylation pathway. Evidence for protein-specific elongation of o-linked fucose in Chinese hamster ovary cells. J. Biol. Chem. 1997, 272:19046-19050.
47. Moloney D.J., et al. Fringe is a glycosyltransferase that modifies Notch. Nature 2000, 406:369-375.
48. Morales J., et al. Homozygous mutations in ADAMTS10 and ADAMTS17 cause lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. Am. J. Hum. Genet. 2009, 85:558-568.
49. Motto D.G., et al. Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J. Clin. Invest. 2005, 115:2752-2761.
50. Nita-Lazar A., Haltiwanger R.S. Methods for analysis of O-linked modifications on epidermal growth factor-like and thrombospondin type 1 repeats. Methods Enzymol. 2006, 417:93-111.
51. Okajima T., et al. Chaperone activity of protein O-fucosyltransferase 1 promotes notch receptor folding. Science 2005, 307:1599-1603.
52. Orr A.W., et al. Thrombospondin stimulates focal adhesion disassembly through Gi- and phosphoinositide 3-kinase-dependent ERK activation. J. Biol. Chem. 2002, 277:20453-20460.
53. Perbal B., et al. Report on the second international workshop on the CCN family of genes. Mol. Pathol. 2003, 56:80-85.
54. Rampal R., et al. Highly conserved O-fucose sites have distinct effects on Notch1 function. J. Biol. Chem. 2005, 280:32133-32140.
55. Ricketts L.M., et al. O-fucosylation is required for ADAMTS13 secretion. J. Biol. Chem. 2007, 282:17014-17023.
56. Sato T., et al. Molecular cloning and characterization of a novel human beta1, 3-glucosyltransferase, which is localized at the endoplasmic reticulum and glucosylates O-linked fucosylglycan on thrombospondin type 1 repeat domain. Glycobiology 2006, 16:1194-1206.
57. Shao L., Haltiwanger R.S. O-fucose modifications of epidermal growth factor-like repeats and thrombospondin type 1 repeats: Unusual modifications in unusual places. Cell. Mol. Life Sci. 2003, 60:241-250.
58. Shi S., Stanley P. Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways. Proc. Natl. Acad. Sci. USA 2003, 100:5234-5239.
59. Shimoyama T., et al. CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration. Arterioscler. Thromb. Vasc. Biol. 2010, 30:675-682.
60. Shindo T., et al. ADAMTS-1: A metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. J. Clin. Invest. 2000, 105:1345-1352.
61. Silver D.L., et al. The secreted metalloprotease ADAMTS20 is required for melanoblast survival. PLoS Genet. 2008, 4:e1000003.
62. Takeuchi H., Haltiwanger R.S. Role of glycosylation of Notch in development. Semin. Cell Dev. Biol. 2010, (in press).
63. Unwin R.D., et al. Relative quantification in proteomics: New approaches for biochemistry. Trends Biochem. Sci. 2006, 31:473-484.
64. Wang Y., et al. Modification of epidermal growth factor-like repeats with O-fucose. Molecular cloning and expression of a novel GDP-fucose protein O-fucosyltransferase. J. Biol. Chem. 2001, 276:40338-40345.
65. Wang L.W., et al. O-fucosylation of thrombospondin type 1 repeats in ADAMTS-like-1/punctin-1 regulates secretion: Implications for the ADAMTS superfamily. J. Biol. Chem. 2007, 282:17024-17031.
66. Wang L.W., et al. Post-translational modification of thrombospondin type-1 repeats in ADAMTS-like 1/punctin-1 by C-mannosylation of tryptophan. J. Biol. Chem. 2009, 284:30004-30015.
67. Williams M.E., et al. UNC5A promotes neuronal apoptosis during spinal cord development independent of netrin-1. Nat. Neurosci. 2006, 9:996-998.
68. Xu A., et al. In vitro reconstitution of the modulation of Drosophila Notch-ligand binding by Fringe. J. Biol. Chem. 2007, 282:35153-35162.
69. Yehualaeshet T., et al. A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat. Am. J. Respir. Cell Mol. Biol. 2000, 23:204-212.
70. Zheng X., et al. ADAMTS13 and TTP. Curr. Opin. Hematol. 2002, 9:389-394.